Iron Oxide Magnetic Particle Composition for Stable Biomedical Heating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Iron oxide magnetic particles used in biomedical applications face challenges such as agglomeration, rapid biodegradation, and instability, leading to changes in magnetic properties and potential toxicity, while existing thermotherapy methods have limitations in heat generation and bioaccumulation.
Innovation Solution
Iron oxide magnetic particles are developed with a transition metal-halogen compound (MXn) where M includes Tl, Pb, Bi, and Po, and X includes F, Cl, Br, and I, forming a stable bond to enhance magnetic properties and reactivity to external stimuli, allowing for efficient heat generation and reduced toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If iron oxide particles are used for thermotherapy, then heat generation ability is improved, but structural stability deteriorates causing crystalline phase changes
Solution Approach 1:
The patent applies composite materials by combining iron oxide particles with a silane-based coating layer. This composite structure allows the iron oxide core to maintain its heat generation ability while the silane coating provides structural stability and prevents crystalline phase changes. The coating layer acts as a protective shell that stabilizes the magnetic properties and prevents transformation to other phases like α-Fe2O3 or γ-Fe2O3.
Solution Approach 2:
The patent employs parameter changes by modifying the surface properties of iron oxide particles through silane coating. This changes the chemical and physical parameters of the particle surface, creating a stable interface that prevents phase transformation while maintaining the core's thermotherapy functionality. The silane coating alters surface energy, hydrophobicity, and chemical reactivity parameters to achieve stability.
2Reliability
If iron oxide particles are used in biomedical applications, then magnetic properties are improved, but toxicity increases due to biodegradation
Solution Approach 1:
The patent uses a silane-based thin film coating to encapsulate the iron oxide particles. This thin film shell provides a protective barrier that reduces biodegradation and toxicity while preserving the magnetic properties of the core. The coating layer acts as an interface between the magnetic core and the biological environment, maintaining reliability while reducing harmful effects.
3Illumination intensity
If iron oxide particles are used for imaging, then contrast effect is improved, but agglomeration occurs due to hydrophobic attraction
Solution Approach 1:
The silane coating changes the surface energy and hydrophobicity parameters of the iron oxide particles. This parameter modification prevents hydrophobic attraction between particles, thereby preventing agglomeration and improving dispersion stability in biological environments while maintaining the contrast effect for imaging applications.
4Temperature
If Co, Ni, and Mg-based MFe2O4 particles are used for thermotherapy, then heat generation is improved, but biocompatibility deteriorates
Solution Approach 1:
The patent uses a silane-based coating as an intermediary layer between the magnetic core and the biological environment. This intermediary provides a biocompatible interface that reduces toxicity and improves safety for in vivo applications while allowing the core to maintain its heat generation capability. The coating acts as a mediator that translates the functional properties of the magnetic material into biocompatible form.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The particles exhibit high structural stability and reactivity, enabling effective use in diagnostic imaging and thermotherapy with reduced toxicity and bioaccumulation, achieving enhanced contrast and thermal energy emission efficiency.
Implementation Method 1
forming a stable bond to enhance magnetic properties and reactivity to external stimuli
Implementation Method 2
magnetic particles have a characteristic of generating heat when radiation or a magnetic field is applied thereto
Implementation Method 3
iron oxide magnetic particles are materials having an indirect band gap in which energy equal to the amount of momentum used is converted into heat and released
Implementation Method 4
Superparamagnetic iron oxide magnetic particles among various types of magnetic particles have been widely studied in the field of biomedicine because of their high magnetic susceptibility and superparamagnetism
Data Source
AI summary
The present invention provides iron oxide magnetic particles containing iron oxide and MXn, wherein M as a transition metal containing electrons in a 6p orbital on the periodic table includes one or more selected from the group consisting of Tl, Pb, Bi, and Po, X includes one or more selected from the group consisting of F, Cl, Br, and I, and n is an integer of 1 to 6.